サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1293682

クリプトコッカス症市場：治療法、流通チャネル別- 世界予測2023-2030年

Cryptococcosis Market by Treatment, Distribution Channel - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
クリプトコッカス症市場：治療法、流通チャネル別- 世界予測2023-2030年
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

クリプトコッカス症の世界市場は大きく成長すると予測され、2023年には59億1,489万米ドルが予測され、CAGRは7.62%、2030年には驚異的な99億650万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のクリプトコッカス症市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.クリプトコッカス症の世界市場規模および予測は？

2.予測期間中、世界のクリプトコッカス症市場を形成するCOVID-19の阻害要因と影響は？

3.クリプトコッカス症の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.クリプトコッカス症の世界市場における競争戦略は？

5.クリプトコッカス症の世界市場における技術動向と規制の枠組みは？

6.クリプトコッカス症の世界市場における主要ベンダーの市場シェアは？

7.クリプトコッカス症の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症と致死性真菌症の蔓延の増加
      • HIV/AIDS関連の洞察を高めるクリプトコッカス症
      • ジェネリック医薬品および市販薬の入手可能性の向上
    • 抑制要因
      • 治療に関する患者の臨床的認識が限られている
      • クリプトコッカス症感染患者の死亡率増加別検査と診断の範囲の縮小
    • 機会
      • クリプト球菌性髄膜炎症の効果的な治療薬開発のための政府の有利なプログラム
      • クリプトコッカス症の医薬品開発の増加と臨床試験エコシステムの進化
    • 課題
      • クリプトコッカス症薬物の使用に伴う副作用
      • 医薬品開発プログラムのニーズと資金不足に対処できていない製薬会社
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 クリプトコッカス症市場治療別

  • アムホテリシンB
  • フルコナゾール
  • フルシトシン

第7章 クリプトコッカス症市場：流通チャネル別

  • 病院薬局
  • 通信販売薬局
  • 小売薬局およびドラッグストア

第8章 南北アメリカのクリプトコッカス症市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のクリプトコッカス症市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのクリプトコッカス症市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CRYPTOCOCCOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. CRYPTOCOCCOSIS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CRYPTOCOCCOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
  • FIGURE 5. CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 6. CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. CRYPTOCOCCOSIS MARKET DYNAMICS
  • FIGURE 8. CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CRYPTOCOCCOSIS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. CRYPTOCOCCOSIS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CRYPTOCOCCOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CRYPTOCOCCOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 5. CRYPTOCOCCOSIS MARKET SIZE, BY AMPHOTERICIN B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CRYPTOCOCCOSIS MARKET SIZE, BY FLUCYTOSINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 9. CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CRYPTOCOCCOSIS MARKET SIZE, BY MAIL ORDER PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. CRYPTOCOCCOSIS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 99. CRYPTOCOCCOSIS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 100. CRYPTOCOCCOSIS MARKET LICENSE & PRICING
目次
Product Code: MRR-4348D129F9A1

The Global Cryptococcosis Market is forecasted to grow significantly, with a projected USD 5,914.89 million in 2023 at a CAGR of 7.62% and expected to reach a staggering USD 9,906.50 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cryptococcosis Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cryptococcosis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Amphotericin B, Fluconazole, and Flucytosine. The Amphotericin B commanded largest market share of 35.12% in 2022, followed by Fluconazole.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Mail Order Pharmacies, and Retail Pharmacies & Drug Stores. The Retail Pharmacies & Drug Stores commanded largest market share of 39.64% in 2022, followed by Hospital Pharmacies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 43.13% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cryptococcosis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cryptococcosis Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cryptococcosis Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cryptococcosis Market?

4. What is the competitive strategic window for opportunities in the Global Cryptococcosis Market?

5. What are the technology trends and regulatory frameworks in the Global Cryptococcosis Market?

6. What is the market share of the leading vendors in the Global Cryptococcosis Market?

7. What modes and strategic moves are considered suitable for entering the Global Cryptococcosis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cryptococcosis Market, by Treatment, 2022 vs 2030
  • 4.3. Cryptococcosis Market, by Distribution Channel, 2022 vs 2030
  • 4.4. Cryptococcosis Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Prevalence of Infectious Diseases and Fatal Fungal Disease
      • 5.1.1.2. Rising Insights into HIV/AIDS-Associated Cryptococcosis
      • 5.1.1.3. Increasing Availability of Generic and Over-the-Counter Medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Clinical Awareness in Patients Regarding Treatments
      • 5.1.2.2. Reduced Scope of Testing and Diagnostics due to Increased Mortality Among Cryptococcosis Infected Patients
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable Government Programs for the Development of Effective Therapeutics for Cryptococcal Meningitis Disease
      • 5.1.3.2. Increasing Drug Development and Evolving Clinical Trial Ecosystem for Cryptococcosis
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects Associated with The Usage of Cryptococcosis Drugs
      • 5.1.4.2. Pharmaceutical Companies Failing to Address The Need and Poorly Funded Drug Development Programs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cryptococcosis Market, by Treatment

  • 6.1. Introduction
  • 6.2. Amphotericin B
  • 6.3. Fluconazole
  • 6.4. Flucytosine

7. Cryptococcosis Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Mail Order Pharmacies
  • 7.4. Retail Pharmacies & Drug Stores

8. Americas Cryptococcosis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cryptococcosis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cryptococcosis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

1. Abbott Laboratories

2. Bausch Health Companies Inc.

3. Bristol-Myers Squibb Company

4. Eisai Co., Ltd.

5. Gilead Sciences, Inc.

6. Glenmark Pharmaceuticals Limited

7. Johnson & Johnson

8. Matinas Biopharma Holdings, Inc.

9. Merck and Co. Inc.

10. Novartis International AG

11. Pfizer Inc.

12. Sanofi S.A.

13. Sigmapharm Laboratories, LLC

14. Skyepharma Production SAS

15. Teva Pharmaceutical Industries Ltd.

16. Viatris Inc.